PSMA-TARGETED IN SITU IMMUNIZATION FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

$1,182,038FY2022Defense Health AgencyDOD

University Of Wisconsin System, Madison WI

Investigators